Pharmaron
Pharmaron
Pharmaron and is committed to helping partners succeed in drug discovery'
Pharmaron is a global pharmaceutical company, biotech company and research institute that provides fully integrated drug discovery, development and manufacturing CRMO solutions across the two stages of drug discovery and drug development, and is committed to helping partners succeed in drug discovery, development and commercialization.
- All
- News
- Analysis
- Research
Briefing Updated 9 hours ago
· Healthcare
Yuanyin biology completed the pre-A round of financing of more than 100 million yuan
Briefing Updated 5 hours ago
· Healthcare
Aibo biology completed the round C + financing of US $300 million
In depth
Healthcare
Bid for Molecular Tech in China's Early-Stage Cancer Detection Market
China, with a population of 1.4 billion, has one of the largest gene pools in the world. How does its DNA tech-based cancer detection industry look? Listed on Nasdaq in 2020, Genetron Holdings Limited (Genetron Health) is taking a leading role.
Sep 09, 2020 03:08 PM
Briefing Nov 21, 2021 05:59 PM
· Healthcare
Pakistan once again lifted the ban on tiktok
Briefing Nov 19, 2021 02:32 PM
· Healthcare
Yinming biological HPK1 small molecule inhibitor new drug has passed the United States ind, and the dry amd small molecule new drug has completed the phase I clinical trial in the United States
Apr 22, 2021 03:11 PM
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Research
Real Estate, Industrials, FinancialsTech for Global, Globalization Footprints of the Established and the New
May 29, 2020 08:30 PM
Briefing Nov 19, 2021 09:30 AM
· Healthcare
Tuochuang biology obtained more than 200 million yuan of round B financing to accelerate the development and clinical promotion of innovative antibody drugs
Briefing Nov 18, 2021 09:22 AM
· Healthcare
Lingtai biology completed the pre-A round of financing and is committed to the development of targeted protein degradation drugs
Briefing Oct 19, 2021 10:11 AM
· Healthcare
Cro stocks rose in early trading
Briefing Sep 23, 2021 10:16 PM
Guangdong relaxes the access threshold for regional headquarters of multinational corporations
Briefing Jul 27, 2021 07:43 PM
· Financials
TPG shangshanruisi climate fund completed the first round of fund-raising, with a scale of US $5.4 billion
Briefing Jul 15, 2021 07:14 PM
· Healthcare
KANGLONG Huacheng: net profit in the first half of the year increased by 4% - 24% year on year
Insight
Briefing Jul 12, 2021 10:20 AM
Cro concept stocks rebounded across the board, and Boteng shares rose 14%
Briefing Jul 06, 2021 10:59 AM
· Healthcare
Blu ray development responds that Huaxia Bank and Vanke will take shares: unconfirmed market rumors
Briefing May 28, 2021 01:51 PM
· Healthcare
Software services strengthen again, Hongmeng concept leads the rise
Briefing Updated 13 hours ago
· Healthcare
2021 Chinese hospital internet influence ranking list released 127 hospitals in 17 provinces and cities
See more
Related Companies
EqualOcean Analysis
- Genetron Health's Self-Developed Mutation Capsule Differentiates It from Others
- Black Swans and Breakthroughs: China's Top 50 Innovative Public Firms in 2020
- China Speed: Two COVID-19 Vaccines Recognized by WHO
- After China's BNR and GTH Hit Nasdaq, Pan-Cancer Detector GRAIL Eyes IPO
- More Room for the Medical Device Market to Grow in China
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.